ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,765Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 817

$768K Total Retail Price of All Prescriptions

Rank: 42 out of 817

708 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 708 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 708 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 437 393 1 3
SIMVASTATIN 431 411 2 1
ATORVASTATIN CALCIUM 424 393 3 9
AMLODIPINE BESYLATE 420 401 4 6
LEVOTHYROXINE SODIUM 390 350 5 2
OMEPRAZOLE 355 313 6 4
ZOLPIDEM TARTRATE 220 199 7 30
LOSARTAN POTASSIUM 219 219 8 29
PRAVASTATIN SODIUM 206 203 9 19
HYDROCHLOROTHIAZIDE 204 193 10 15
SYNTHROID 201 195 11 36
METOPROLOL TARTRATE 198 195 12 5
SERTRALINE HCL 181 169 13 24
CITALOPRAM HBR 156 155 14 16
FLUTICASONE PROPIONATE 154 138 15 48
FUROSEMIDE 154 148 15 8
WARFARIN SODIUM 148 144 17 10
METFORMIN HCL 145 144 18 13
GABAPENTIN 144 135 19 12
TAMSULOSIN HCL 139 139 20 11
DIOVAN 126 126 21 28
NEXIUM 120 116 22 57
ATENOLOL 120 115 22 14
AZITHROMYCIN 118 111 24 53
CARVEDILOL 117 117 25 21
PANTOPRAZOLE SODIUM 99 87 26 22
ZETIA 98 98 27 47
ALLOPURINOL 89 89 28 50
HYDROCODONE-ACETAMINOPHEN 86 73 S3 29 7
JANUVIA 86 73 29 66
METOPROLOL SUCCINATE 85 72 31 26
DETROL LA 82 82 32 113
POTASSIUM CHLORIDE 80 68 33 18
ADVAIR DISKUS 79 67 34 32
ALENDRONATE SODIUM 79 77 34 31
DONEPEZIL HCL 74 74 36 20
RANITIDINE HCL 71 61 37 42
PREDNISONE 69 61 38 17
CELEBREX 69 67 38 65
KLOR-CON M20 66 63 40 61
TRIAMTERENE-HCTZ 66 61 40 98
VENLAFAXINE HCL ER 64 63 42 69
GLIMEPIRIDE 63 59 43 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 60 44 70
CIPROFLOXACIN HCL 60 58 45 39
CLOPIDOGREL 59 57 46 27
MIRTAZAPINE 56 56 47 40
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 47 107
FLUOXETINE HCL 55 23 49 87
METHYLPREDNISOLONE 55 49 49 119
LIPITOR 54 54 51 126
DIOVAN HCT 54 54 51 95
DILTIAZEM 24HR ER 54 54 51 91
ENALAPRIL MALEATE 53 53 54 79
VALACYCLOVIR 52 43 55 329
PAROXETINE HCL 50 50 56 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.